Two weeks ago, we celebrated my father-in-law’s 80th birthday at a restaurant. He could walk and manage on his own although he had bouts of pain. It has been 3 years and 3 months since the initial diagnosis.
My father-in-law is now in the hospital. He is too weak to walk or even sit up. He can no longer talk or eat. He survives on an IV drip. He is in constant horrible pain such that he is continually moaning and crying. Only the morphine provides release.
When he is discharged from the hospital, he will be moved to hospice where he will stay until death. This is not how you want to die.
The only shining light is that my wife and her sisters are constantly at his side, holding his hand and talking with him. He is lucky in this sense as no one else in his ward has visitors that are constantly at their side. Too many elderly die alone.
The best treatment for cancer is prevention. That’s a big reason why many of us are taking Rapamycin. Cancer is a horrible way to die.
He took 1 mg of Rapamycin daily (off and on) since June. It appears that dose had no effect. A higher dose may have worked better, but he didn’t want to try that.
Increasingly, researchers are adopting the view that it makes sense to regard and treat cancer as a metabolic disease primarily. Yes, it may be instigated by a mutation of other insult to the cell, but the best way to stop it is to make its environment inhospitable to growth. Witness the research focusing on the TME tumor microenvironment. This is approach is also central to Jason Fong’s view in The Cancer Code, and aligns with the emerging view that most disease has an underlying metabolic component. For a practical and comprehensive approach, Jane Mclelland “How to Starve Cancer without Starving Yourself.” She provides specific strategies including some of the things discussed above: doxicycline and other antibiotics, metformin, melatonin, helminths (dewormers) such as fenbendazole. Why does a dewormer work so well against cancer?
If you read Fong you learn that a cancer cell is a cell that has gone into survival mode and has jettisoned its higher level programming and its role as a cooperative member of a complex eukaryotic multi-cell organism. A cancer cell is in heavy growth, every man for himself mode. Having been “injured,” has dropped back to a level of function that makes it behave like a simple single cell organism, abandoning its specialized higher level functioning and it role in the larger society/organism. So a drug like fenbendazole that attacks a simple organism is effective in attacking a cancer cell.
Mclelland together with Fong are by far the most insightful and also practical books I have read on cancer genesis, behavior, and treatment. Cannot recommend highly enough.
The publication @Chronos Tempi mentions contains valuable info on which food stuffs diminish the effect of statins. Especially geranylgeraniol present in may common things we may eat or drink like green tea, lettuce and many more may be damaging if statins are needed.
The full article is also in europepmc.org if you type 35111242 .
It makes me reconsider the use of green tea as an anti-oxidant
This is important because Geranylgeraniol (GG) Supplements have been recommended here when taking statins to relieve muscle discomfort and fatigue, if CoQ10 doesn’t work. GG is promoted as a more effective CoQ10. Pitavastatin is supposed to have little (or no) muscle effects. From the paper:
We have previously shown that the potential activity of statins as a cancer treatment depends on the reduced production of geranylgeraniol. However, several human foods have been reported to contain geranylgeraniol, potentially bypassing the effect of the statins on the cancer cells.We have previously shown that geranylgeraniol, but not farnesol, reverses the activity of pitavastatin or simvastatin (6,8). Here we extended this and tested other products of the mevalonate pathway whose biosynthesis would also be anticipated to be blocked by statins. However, addition of coenzyme Q, dolichol or cholesterol had no effect on the activity of pitavastatin whereas geranylgeraniol did. Thus, we acknowledge that it remains a formal possibility that the ingestion of foods containing geranylgeraniol has minimal effect on the activity of statins as anti-cancer agents because insufficient geranylgeraniol reaches the systemic circulation from dietary sources.
